{"schema_version":"secwatch.filing_event.v1","accession":"0000014272-23-000018","form_type":"8-K","ticker":"BMY","cik":"0000014272","company_name":"BRISTOL MYERS SQUIBB CO","filed_at":"2023-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.895378+00:00","generated_at":"2026-06-20T02:10:07.663095+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Bristol Myers Q4 revenue $11.4B, GAAP EPS $0.95; full-year $46.2B, EPS $2.95; in-line/new product portfolio grows 7%","bullets":["Q4 2022 revenues $11,406M (-5% YoY); full-year $46,159M (flat YoY).","GAAP EPS: Q4 $0.95, full-year $2.95; Non-GAAP EPS: Q4 $1.82, full-year $7.70.","In-Line and New Product Portfolio revenues up 7% (12% ex-FX) Q4; full-year up 9% (13% ex-FX).","Revlimid revenues declined 32% Q4 and 22% full-year due to loss of exclusivity.","2023 GAAP and non-GAAP guidance provided reflecting continued revenue and earnings growth."],"urls":{"canonical":"https://secwatch.observer/filing/0000014272-23-000018","json":"https://secwatch.observer/filing/0000014272-23-000018.json","markdown":"https://secwatch.observer/filing/0000014272-23-000018.md","text":"https://secwatch.observer/filing/0000014272-23-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/14272/000001427223000018/0000014272-23-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/14272/000001427223000018/bmy-20230202.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T02:10:07.663095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01c650d303f3def5951a7b7f2df8651256e92124","claim":"BRISTOL MYERS SQUIBB CO reported the fourth quarter of 2022 results: revenue $11.4 Billion, EPS $0.95.","evidence_excerpt":"• Reports Fourth Quarter Revenues of $11.4 Billion; Full-Year Revenues of $46.2 Billion ◦ Fourth Quarter Revenues from In-Line Products and New Product Portfolio were $9.0 Billion, an Increase of 7%, or 12% When Adjusted for Foreign Exchange ◦ Full-Year Revenues from In-Line Products and New Product Portfolio were $35.4 Billion, an Increase of 9%, or 13% When Adjusted for Foreign Exchange • Posts Fourth Quarter GAAP EPS of $0.95 and Non-GAAP EPS of $1.82; Includes Net Impact of ($0.01) Per Share for GAAP and Non-GAAP EPS Due to Acquired IPRD Charges and Licensing Income","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/14272/000001427223000018/0000014272-23-000018-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter of 2022"},{"label":"Revenue","value":"$11.4 Billion"},{"label":"EPS","value":"$0.95"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"5086199e12e59cc6ce3d7b6594fb40b28bd6a141","claim":"BRISTOL MYERS SQUIBB CO updated its 2023 guidance (initiated).","evidence_excerpt":"• Provides GAAP and Non-GAAP Financial Guidance for 2023 Reflecting Continued Revenue and Earnings Growth","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/14272/000001427223000018/0000014272-23-000018-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"2023"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"d9bbccb58528e00374936063d41beeecf6d0e281","claim":"BRISTOL MYERS SQUIBB CO reported full year of 2022 results: revenue $46.2 Billion, EPS $2.95.","evidence_excerpt":"• Reports Fourth Quarter Revenues of $11.4 Billion; Full-Year Revenues of $46.2 Billion ◦ Fourth Quarter Revenues from In-Line Products and New Product Portfolio were $9.0 Billion, an Increase of 7%, or 12% When Adjusted for Foreign Exchange ◦ Full-Year Revenues from In-Line Products and New Product Portfolio were $35.4 Billion, an Increase of 9%, or 13% When Adjusted for Foreign Exchange • Posts Fourth Quarter GAAP EPS of $0.95 and Non-GAAP EPS of $1.82; Includes Net Impact of ($0.01) Per Share for GAAP and Non-GAAP EPS Due to Acquired IPRD Charges and Licensing Income • Reports Full-Year GAAP EPS of $2.95 and Non-GAAP EPS of $7.70; Includes Net Impact of ($0.24) Per Share for GAAP and Non-GAAP EPS Due to Acquired IPRD Charges and Licensing Income","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/14272/000001427223000018/0000014272-23-000018-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year of 2022"},{"label":"Revenue","value":"$46.2 Billion"},{"label":"EPS","value":"$2.95"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}